Artificial Intelligence

With 13,000 attendees and a bold expansion to Ras Al Khaimah, AIBC Eurasia 2026 highlights a major shift of tech's center of power to the East.

Allocate's 350% asset growth signals a major shift as wealth advisors embrace private markets. Discover how its AI-powered platform is making it possible.

A new health tech company has assembled a star-studded scientific board to back its AI-powered dementia prevention app. But can it deliver on its promise?

VIAVI's new ePRTC360+ meets stringent timing standards without Cesium, offering a cheaper, more resilient solution for critical infrastructure.

With a new $12M investment, Lightworks aims to help large firms move AI from pilot to production by solving the critical challenges of safety and compliance.

New long-term data shows duvakitug maintained remission in IBD patients for nearly a year, positioning it as a top contender in a new class of therapy.

A new report reveals how open source AI is fueling India's explosive market growth, creating a global talent hub, and tackling deep-seated social challenges.

As copper phone lines vanish, Ooma's new POTSTracker.com uses AI to help businesses find and replace critical legacy connections before they fail.

The new patent protects a technology that stabilizes 'undruggable' proteins, paving the way for next-gen drugs and fortifying the company's market position.

Tech titans like Micron, NVIDIA, and Applied Materials join forces in a $2.5B alliance to forge India into a global deep tech powerhouse.

A new partnership combines AI design with rapid lab testing to crack the code of complex proteins, speeding up drug discovery and opening new frontiers.

Forget simple indicators. A new breed of retail trader uses complex data, automation, and strict risk rules to gain a professional edge in the market.

A new international board of industry veterans aims to steer AML RightSource's global strategy amid rising crypto crime and complex regulations.

Oculis appoints former Cooley partner Katie Kazem as CLO, a strategic move to fortify governance ahead of pivotal data readouts for its late-stage eye drugs.

IDC MarketScape recognizes Hitachi Energy's leadership in asset management as utilities race to balance aging grids with a clean energy future.

The Israeli defense giant adds to its massive $25.2B backlog with new contracts for land systems and a future-oriented innovative defense solution.

With a bolstered cash runway from recent funding, Inventiva is all-in on its MASH drug, lanifibranor, racing against giants in a multi-billion dollar market.

A Swedish biotech and Belgian university secure major EU funding to advance a first-in-class drug against glioblastoma, a notoriously deadly brain tumor.

Nawal Ouzren steps down as CEO for personal reasons just after a €60M financing. Chairman Amit Munshi takes over as the biotech faces key milestones.

Strategic operator Exa Capital acquires clinical workforce leader StaffReady, betting its 'forever' investment model can boost healthcare efficiency.